Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis

Abstract Background In muscle-invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) combined with radical cystectomy (RC) is critical in reducing disease recurrence, with GC (gemcitabine and cisplatin) being one of the most commonly used NACs. Different GC schedules have been used, but the...

Full description

Bibliographic Details
Published in:BMC Cancer
Main Authors: Lanpeng Lu, Chaohu Chen, Hui Cheng, Hui Ding, Junqiang Tian, Hanzhang Wang, Zhiping Wang
Format: Article
Language:English
Published: BMC 2023-11-01
Subjects:
Bladder cancer
Neoadjuvant chemotherapy
Gemcitabine
Cisplatin
Online Access:https://doi.org/10.1186/s12885-023-11572-0

Internet

https://doi.org/10.1186/s12885-023-11572-0

Similar Items